You can help our author matching system! If you notice any publications incorrectly attributed to this author, please
sign in and mark matches as correct or incorrect.
|
Mukherjee G, Nandekar PP, Wade RC. (2021) An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase. Communications Biology. 4: 55 |
Mustafa G, Nandekar PP, Mukherjee G, et al. (2020) The Effect of Force-Field Parameters on Cytochrome P450-Membrane Interactions: Structure and Dynamics. Scientific Reports. 10: 7284 |
Mustafa G, Nandekar PP, Bruce NJ, et al. (2019) Differing Membrane Interactions of Two Highly Similar Drug-Metabolizing Cytochrome P450 Isoforms: CYP 2C9 and CYP 2C19. International Journal of Molecular Sciences. 20 |
Mustafa G, Nandekar PP, Camp TJ, et al. (2019) Influence of Transmembrane Helix Mutations on Cytochrome P450-Membrane Interactions and Function. Biophysical Journal |
Douglas RG, Nandekar P, Aktories JE, et al. (2018) Inter-subunit interactions drive divergent dynamics in mammalian and Plasmodium actin filaments. Plos Biology. 16: e2005345 |
Kesharwani SS, Nandekar PP, Pragyan P, et al. (2016) Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations. Journal of Molecular Recognition : Jmr. 29: 370-90 |
Mustafa G, Nandekar PP, Yu X, et al. (2015) On the application of the MARTINI coarse-grained model to immersion of a protein in a phospholipid bilayer. The Journal of Chemical Physics. 143: 243139 |
Yu X, Nandekar P, Mustafa G, et al. (2015) Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design. Biochimica Et Biophysica Acta. 1860: 67-78 |
Kesharwani SS, Nandekar PP, Pragyan P, et al. (2014) Comparative proteomics among cytochrome p450 family 1 for differential substrate specificity. The Protein Journal. 33: 536-48 |
Rathod V, Jain S, Nandekar P, et al. (2014) Human pregnane X receptor: a novel target for anticancer drug development. Drug Discovery Today. 19: 63-70 |